Kiyomitsu Fukaguchi

Kiyomitsu Fukaguchi

Auto-generated profile, based on publicly available information

Kiyomitsu Fukaguchi

Shonan Kamakura General Hospital

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in JMIR Medical Education
Verified
Journal Article
Open access
NINaoki Ito
Naoki Ito
SKSakina Kadomatsu
Sakina Kadomatsu
MFMineto Fujisawa
Mineto Fujisawa
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
RIRyo Ishizawa
Ryo Ishizawa
YTYusuke Tsugawa
Yusuke Tsugawa
Background: Whether GPT-4, the conversational artificial intelligence, can accurately diagnose and triage health conditions and whether it presents racial and ethnic biases in its decisions remain unclear. Objective: We aim to assess the accuracy of GPT-4 in the diagnosis and triage of health conditions and whether its performance varies by patient race and ethnicity. Methods: We compared the performance of GPT-4 and physicians, using 45 typical clinical vignettes, each with a correct diagnosis and triage level, in February and March 2023. For each of the 45 clinical vignettes, GPT-4 and 3 board-certified physicians provided the most likely primary diagnosis and triage level (emergency, nonemergency, or self-care). Independent reviewers evaluated the diagnoses as “correct” or “incorrect.” Physician diagnosis was defined as the consensus of the 3 physicians. We evaluated whether the performance of GPT-4 varies by patient race and ethnicity, by adding the information on patient race and ethnicity to the clinical vignettes. Results: The accuracy of diagnosis was comparable between GPT-4 and physicians (the percentage of correct diagnosis was 97.8% (44/45; 95% CI 88.2%-99.9%) for GPT-4 and 91.1% (41/45; 95% CI 78.8%-97.5%) for physicians; P=.38). GPT-4 provided appropriate reasoning for 97.8% (44/45) of the vignettes. The appropriateness of triage was comparable between GPT-4 and physicians (GPT-4: 30/45, 66.7%; 95% CI 51.0%-80.0%; physicians: 30/45, 66.7%; 95% CI 51.0%-80.0%; P=.99). The performance of GPT-4 in diagnosing health conditions did not vary among different races and ethnicities (Black, White, Asian, and Hispanic), with an accuracy of 100% (95% CI 78.2%-100%). P values, compared to the GPT-4 output without incorporating race and ethnicity information, were all .99. The accuracy of triage was not significantly different even if patients’ race and ethnicity information was added. The accuracy of triage was 62.2% (95% CI 46.5%-76.2%; P=.50) for Black patients; 66.7% (95% CI 51.0%-80.0%; P=.99) for White patients; 66.7% (95% CI 51.0%-80.0%; P=.99) for Asian patients, and 62.2% (95% CI 46.5%-76.2%; P=.69) for Hispanic patients. P values were calculated by comparing the outputs with and without conditioning on race and ethnicity. Conclusions: GPT-4’s ability to diagnose and triage typical clinical vignettes was comparable to that of board-certified physicians. The performance of GPT-4 did not vary by patient race and ethnicity. These findings should be informative for health systems looking to introduce conversational artificial intelligence to improve the efficiency of patient diagnosis and triage.

28 June 2008 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MYMasashi Yamada
Masashi Yamada
YSYasuhiro Sumida
Yasuhiro Sumida
AFAkemi Fujibayashi
Akemi Fujibayashi
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
NSNoriko Sanzen
Noriko Sanzen
KSKiyotoshi Sekiguchi
Kiyotoshi Sekiguchi
The tetraspanin CD151 forms a stable complex with integrin α3β1, a widely expressed laminin receptor, and is implicated in the regulation of integrin α3β1‐mediated cellular responses, including cell attachment, spreading and migration. However, the molecular mechanism by which CD151 regulates integrin α3β1 functions remains unclear. To address this issue, we knocked down CD151 expression in A549 human lung adenocarcinoma cells by RNA interference. When plated on laminin‐511 (laminin‐10), the CD151‐knocked‐down cells showed aberrant membrane protrusions and exhibited reductions in the tyrosine phosphorylation of focal adhesion kinase, Src, p130Cas and paxillin. The formation of membrane protrusions was attenuated when the cells were either plated on surfaces coated with higher concentrations of laminin‐511 or treated with the integrin β1‐activating mAb TS2/16; however, neither treatment could rescue the reduced tyrosine phosphorylation. These results indicate that CD151 knockdown weakens the integrin α3β1‐mediated adhesion to laminin‐511 and thereby provokes an aberrant morphology, but this reduced adhesive activity is not involved in the decline of signaling events in CD151‐knocked‐down cells. Thus, our results suggest that CD151 regulates integrin α3β1 functions in two independent aspects: potentiation of integrin α3β1‐mediated cell adhesion and promotion of integrin α3β1‐stimulated signaling events involving tyrosine phosphorylation.

6 July 2022 in JMIR Formative Research
Verified
Journal Article
Open access
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
TGTadahiro Goto
Tadahiro Goto
TYTadatsugu Yamamoto
Tadatsugu Yamamoto
HYHiroshi Yamagami
Hiroshi Yamagami
Background: With the aging society, the number of emergency transportations has been growing. Although it is important that a patient be immediately transported to an appropriate hospital for proper management, accurate diagnosis in the prehospital setting is challenging. However, at present, patient information is mainly communicated by telephone, which has a potential risk of communication errors such as mishearing. Sharing correct and detailed prehospital information with emergency departments (EDs) should facilitate optimal patient care and resource use. Therefore, the implementation of an app that provides on-site, real-time information to emergency physicians could be useful for early preparation, intervention, and effective use of medical and human resources. Objective: In this paper, we aimed to examine whether the implementation of a mobile app for emergency medical service (EMS) would improve patient outcomes and reduce transportation time as well as communication time by phone (ie, phone-communication time). Methods: We performed an interrupted time-series analysis (ITSA) on the data from a tertiary care hospital in Japan from July 2021 to October 2021 (8 weeks before and 8 weeks after the implementation period). We included all patients transported by EMS. Using the mobile app, EMS can send information on patient demographics, vital signs, medications, and photos of the scene to the ED. The outcome measure was inpatient mortality and transportation time, as well as phone-communication time, which was the time for EMS to negotiate with ED staffs for transport requests. Results: During the study period, 1966 emergency transportations were made (n=1033, 53% patients during the preimplementation period and n=933, 47% patients after the implementation period). The ITSA did not reveal a significant decrease in patient mortality and transportation time before and after the implementation. However, the ITSA revealed a significant decrease in mean phone-communication time between pre- and postimplementation periods (from 216 to 171 seconds; −45 seconds; 95% CI −71 to −18 seconds). From the pre- to postimplementation period, the mean transportation time from EMS request to ED arrival decreased by 0.29 minutes (from 36.1 minutes to 35.9 minutes; 95% CI −2.20 to 1.60 minutes), without change in time trends. We also introduced cases where the app allowed EMS to share accurate and detailed prehospital information with the emergency department, resulting in timely intervention and reducing the burden on the ED. Conclusions: The implementation of a mobile app for EMS was associated with reduced phone-communication time by 45 seconds (22%) without increasing mortality or overall transportation time despite the implementation of new methods in the real clinical setting. In addition, real-time patient information sharing, such as the transfer of monitor images and photos of the accident site, could facilitate optimal patient care and resource use.

1 August 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
HYHiroshi Yamagami
Hiroshi Yamagami
SSShoko Soeno
Shoko Soeno
KHKonan Hara
Konan Hara
TSToru Shirakawa
Toru Shirakawa
TGTadahiro Goto
Tadahiro Goto
Serum potassium levels are considered as a marker of cerebrovascular emergencies but there is less clarity on the association between initial serum potassium levels recorded on patient's arrival at the emergency department with the type of stroke. This is a case-control study using data of a tertiary care hospital in Japan from April 2018 to September 2019. We identified adult patients with hemorrhagic stroke including subarachnoid hemorrhage (cases) and those with ischemic stroke (controls). Data on age, sex, chief complaints, vital signs, and initial blood tests were collected. We analyzed the association between serum potassium levels and the type of stroke by drawing a LOWESS curve. Additionally, we fitted a logistic regression model to examine the association of interest. There were 416 stroke patients (158 hemorrhagic and 258 ischemic). The median age was 77 years (IQR: 68, 84), and 54% were male. The mean potassium level was 3.69 ± 0.55 mEq/L for hemorrhagic stroke and 4.08 ± 0.65 mEq/L for ischemic stroke. The LOWESS curve showed that the lower initial potassium level was linearly associated with a greater likelihood of hemorrhagic stroke. In the logistic regression model, the odds ratio for the risk of hemorrhagic stroke per 1 mEq/L lower potassium level was 3.31 (95% confidence interval [CI]: 2.24-5.04). This association remained significant in a multivariable model adjusting for other covariates (OR: 2.62 [95% CI: 1.70-4.16]). Initial potassium level was lower in patients with hemorrhagic stroke compared to those with ischemic stroke.

20 July 2022 in American Journal of Case Reports
Verified
Journal Article
Open access
YIYo Ishihara
Yo Ishihara
HFHiroyuki Fukui
Hiroyuki Fukui
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
ISIchiro Sekine
Ichiro Sekine
HYHiroshi Yamagami
Hiroshi Yamagami
Unusual clinical course Severe hypothermia has a high mortality rate and necessitates aggressive warming to save lives. One of the most effective treatments for severe hypothermia is intravascular rewarming. Intravascular recuperative warming can be delivered by inserting a catheter through the cervical or femoral veins. Catheter insertion through the femoral vein is a commonly performed procedure with fewer complications than catheter insertion through the internal jugular vein. This procedure is commonly conducted by inserting a central venous catheter through the femoral vein. When a catheter is inserted through the femoral vein, a frontal abdominal radiograph is often used to confirm the position of the catheter tip. We present the case of a 58-year-old Japanese man who had severe hypothermia. Under ultrasound guidance, a catheter was inserted through the femoral vein into the inferior vena cava for active rewarming. A frontal abdominal radiograph showed that a catheter tip appeared to be in the inferior vena cava. However, a subsequent computed tomography scan revealed that the catheter tip had been misplaced into the right ascending lumbar vein. Catheters may stray into the right ascending lumbar vein if they are placed through the right femoral vein. Frontal abdominal radiographs may be insufficient to confirm catheter placement.

25 April 2025 in Transfusion
Verified
Journal Article
Open access
TKTadashi Kamio
Tadashi Kamio
MIMasaru Ikegami
Masaru Ikegami
MMMegumi Mizuno
Megumi Mizuno
SISeiichiro Ishii
Seiichiro Ishii
HTHayato Tajima
Hayato Tajima
KFKiyomitsu Fukaguchi
Kiyomitsu Fukaguchi
Background: The increasing use of extracorporeal membrane oxygenation (ECMO) has highlighted challenges in managing bleeding complications. Optimal transfusion strategies remain uncertain for this diverse patient group, necessitating accurate predictive tools. This study developed and validated a machine learning (ML) algorithm to predict bleeding complications in patients with ECMO, using red blood cell (RBC) transfusion as a surrogate marker.Methods: Data from the Tokushukai Medical Database (2018–2022), covering 71 hospitals, were used. An ML approach was employed to predict bleeding complications, using RBC transfusion events as a surrogate marker. Model performance was evaluated using precision, recall, F1 score, and accuracy. SHapley Additive exPlanations (SHAP) analysis was conducted to identify key factors influencing model predictions.Results: Out of 470 ECMO‐treated intensive care unit patients, 357 were included for model development. Forty‐seven variables were used, with the light gradient boosting machine (LightGBM) and random forest models performing better than the other models, with receiver operating characteristic (ROC) area under the curve (AUC) above 0.7 for both (accuracy: 70.5%, ROC AUC: 0.703, recall: 0.784, and ROC AUC: 0.705, respectively). Models such as extreme gradient boosting performed similarly, while support vector classification had the lowest performance. SHAP analysis identified circulating blood volume, hemoglobin, and weight as the most important predictive factors.Discussion: The LightGBM and Random Forest models effectively predict bleeding complications in patients with ECMO, using RBC transfusion as a surrogate marker. This tool can support early identification of high‐risk patients and improve overall transfusion management.